These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 22505596)

  • 1. Ginkgo May Sensitize Ovarian Cancer Cells to Cisplatin: Antiproliferative and Apoptosis-Inducing Effects of Ginkgolide B on Ovarian Cancer Cells.
    Jiang W; Cong Q; Wang Y; Ye B; Xu C
    Integr Cancer Ther; 2014 May; 13(3):NP10-7. PubMed ID: 22505596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
    Liu Y; Chen X; Luo Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways.
    Shen W; Liang B; Yin J; Li X; Cheng J
    Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitor of signal transducer and activator of transcription 3 (STAT3) suppresses ovarian cancer growth, migration and invasion and enhances the effect of cisplatin in vitro.
    Tang YJ; Sun ZL; Wu WG; Xing J; He YF; Xin DM; Han P
    Genet Mol Res; 2015 Mar; 14(1):2450-60. PubMed ID: 25867391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
    Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G
    Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginkgo may prevent genetic-associated ovarian cancer risk: multiple biomarkers and anticancer pathways induced by ginkgolide B in BRCA1-mutant ovarian epithelial cells.
    Jiang W; Qiu W; Wang Y; Cong Q; Edwards D; Ye B; Xu C
    Eur J Cancer Prev; 2011 Nov; 20(6):508-17. PubMed ID: 21857521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR214-regulated p53-NOX4/p66shc pathway plays a crucial role in the protective effect of Ginkgolide B against cisplatin-induced cytotoxicity in HEI-OC1 cells.
    Ma W; Li J; Hu J; Cheng Y; Wang J; Zhang X; Xu M
    Chem Biol Interact; 2016 Feb; 245():72-81. PubMed ID: 26768586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginkgolide B reduces neuronal cell apoptosis in the hemorrhagic rat brain: possible involvement of Toll-like receptor 4/nuclear factor-kappa B pathway.
    Hu YY; Huang M; Dong XQ; Xu QP; Yu WH; Zhang ZY
    J Ethnopharmacol; 2011 Oct; 137(3):1462-8. PubMed ID: 21878382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of recombinant human interleukin-24 alone and in combination with cisplatin on the growth of ovarian cancer cells in vitro].
    Wang S; Guo J; Tang Y; Zheng R; Song M; Sun W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jan; 30(1):33-6. PubMed ID: 24405596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alkaloids from Stephania venosa as Chemo-Sensitizers in SKOV3 Ovarian Cancer Cells via Akt/NF-κB Signaling.
    Mon MT; Yodkeeree S; Punfa W; Pompimon W; Limtrakul P
    Chem Pharm Bull (Tokyo); 2018; 66(2):162-169. PubMed ID: 29386467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel CRAd in combination with cisplatin enhanced the antitumor efficacy in ovarian cancer.
    Zhang B; Liu Y; Zhang P; Wei Y; Yin X; Zheng J
    Int J Gynecol Cancer; 2011 Dec; 21(9):1540-6. PubMed ID: 22080895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of that synergistic effect of cisplatin combined with compound herbal medicinal prescription for tonic quality and activating blood circulation is on SKOV3 cell proliferation and apoptosis].
    Suo YP; Wang BY; Hong Z; Yin RT; Wang DQ; Peng ZL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):542-6. PubMed ID: 16909597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salinomycin inhibits Akt/NF-κB and induces apoptosis in cisplatin resistant ovarian cancer cells.
    Parajuli B; Lee HG; Kwon SH; Cha SD; Shin SJ; Lee GH; Bae I; Cho CH
    Cancer Epidemiol; 2013 Aug; 37(4):512-7. PubMed ID: 23545383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginkgolide B enhances gemcitabine sensitivity in pancreatic cancer cell lines via inhibiting PAFR/NF-кB pathway.
    Lou C; Lu H; Ma Z; Liu C; Zhang Y
    Biomed Pharmacother; 2019 Jan; 109():563-572. PubMed ID: 30399592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule inhibitor of c-Met (PHA665752) suppresses the growth of ovarian cancer cells and reverses cisplatin resistance.
    Li E; Hu Z; Sun Y; Zhou Q; Yang B; Zhang Z; Cao W
    Tumour Biol; 2016 Jun; 37(6):7843-52. PubMed ID: 26695152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment with the γ-secretase inhibitor DAPT sensitizes drug-resistant ovarian cancer cells to cisplatin by downregulation of Notch signaling.
    Wang M; Ma X; Wang J; Wang L; Wang Y
    Int J Oncol; 2014 Apr; 44(4):1401-9. PubMed ID: 24535252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential combination therapy of ovarian cancer with cisplatin and γ-secretase inhibitor MK-0752.
    Chen X; Gong L; Ou R; Zheng Z; Chen J; Xie F; Huang X; Qiu J; Zhang W; Jiang Q; Yang Y; Zhu H; Shi Z; Yan X
    Gynecol Oncol; 2016 Mar; 140(3):537-44. PubMed ID: 26704638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginkgolide B protects against cisplatin-induced ototoxicity: enhancement of Akt-Nrf2-HO-1 signaling and reduction of NADPH oxidase.
    Ma W; Hu J; Cheng Y; Wang J; Zhang X; Xu M
    Cancer Chemother Pharmacol; 2015 May; 75(5):949-59. PubMed ID: 25749575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xiaoaiping combined with cisplatin can inhibit proliferation and invasion and induce cell cycle arrest and apoptosis in human ovarian cancer cell lines.
    Zheng AW; Chen YQ; Fang J; Zhang YL; Jia DD
    Biomed Pharmacother; 2017 May; 89():1172-1177. PubMed ID: 28320083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance in cisplatin-resistant ovarian carcinoma cell line.
    Du P; Zhang X; Liu H; Chen L
    DNA Cell Biol; 2015 Jul; 34(7):497-502. PubMed ID: 25941922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.